Indirect comparison studies--are they useful? Insights from the novel oral anticoagulants for stroke prevention in atrial fibrillation.

Gregory Lip, Isabelle Van Gelder, Jeroen Bax, Elaine Hylek, Stefan Kääb, Ulrich Schotten, Karl Wegscheider, Giuseppe Boriani, Michael Ezekowitz, Hans Diener, Hein Heidbuchel, Deirdre Lane, Luis Mont, Stephan Willems, Paul Dorian, Panos Vardas, Günter Breithardt, A. John Camm, Paulus Kirchhof, Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options Executive summary* of the report from the 3rd AFNET/EHRA consensus conference Thrombosis and Haemostasis. ,vol. 106, pp. 1012- 1019 ,(2011) , 10.1160/TH11-07-0517

S. J. Edwards, M. J. Clarke, S. Wordsworth, J. Borrill, Indirect comparisons of treatments based on systematic reviews of randomised controlled trials. International Journal of Clinical Practice. ,vol. 63, pp. 841- 854 ,(2009) , 10.1111/J.1742-1241.2009.02072.X

Gregory Lip, Karlheinz Peter, Ingo Ahrens, New oral anticoagulant drugs in cardiovascular disease Thrombosis and Haemostasis. ,vol. 104, pp. 49- 60 ,(2010) , 10.1160/TH09-05-0327

Robert Storey, Education in atherothrombosis Thrombosis and Haemostasis. ,vol. 105, ,(2011) , 10.1160/THS11-03-0151

Arlene Gallagher, Efrosini Setakis, Jonathan Plumb, Andreas Clemens, Tjeerd-Pieter van Staa, Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thrombosis and Haemostasis. ,vol. 106, pp. 968- 977 ,(2011) , 10.1160/TH11-05-0353

Heiner C. Bucher, Gordon H. Guyatt, Lauren E. Griffith, Stephen D. Walter, The Results of Direct and Indirect Treatment Comparisons in Meta-Analysis of Randomized Controlled Trials Journal of Clinical Epidemiology. ,vol. 50, pp. 683- 691 ,(1997) , 10.1016/S0895-4356(97)00049-8

Laurent Gorin, Emilie Nonin, Axel de Labriolle, Ken Haguenoer, Pierre Cosnay, Dominique Babuty, Bernard Charbonnier, Laurent Fauchier, Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1 Thrombosis and Haemostasis. ,vol. 103, pp. 833- 840 ,(2010) , 10.1160/TH09-10-0746

John W. Eikelboom, Ganesan Karthikeyan, The CHADS2 score for stroke risk stratification in atrial fibrillation--friend or foe? Thrombosis and Haemostasis. ,vol. 104, pp. 45- 48 ,(2010) , 10.1160/TH09-11-0757

Gregory Y. H. Lip, Herbert Noack, Andreas Clemens, Jonathan M. Plumb, Neil S. Roskell, Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate. Thrombosis and Haemostasis. ,vol. 104, pp. 1106- 1115 ,(2010) , 10.1160/TH10-10-0642

Ajay K Kakkar, Iris Mueller, Jean-Pierre Bassand, David A Fitzmaurice, Samuel Z Goldhaber, Shinya Goto, Sylvia Haas, Werner Hacke, Gregory YH Lip, Lorenzo G Mantovani, Freek WA Verheugt, Waheed Jamal, Frank Misselwitz, Sophie Rushton-Smith, Alexander GG Turpie, None, International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD) American Heart Journal. ,vol. 163, pp. 13- 19.e1 ,(2012) , 10.1016/J.AHJ.2011.09.011